ROCKWELL MEDICAL, INC. Selling, General and Administrative Expense
ROCKWELL MEDICAL, INC. (RMTI) reported Selling, General and Administrative Expense of $23.08 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2019-03-18
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2018-12-31 was $7.90M, a 34.59% increase year-over-year.
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2018-09-30 was $6.16M, a 28.54% increase year-over-year.
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2018-06-30 was $5.69M, a 13.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2018-03-31 was $3.33M, a 45.38% decline year-over-year.
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for fiscal 2018 was $23.08M, a 0.95% decline from fiscal 2017.
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for fiscal 2017 was $23.30M, a 10.33% increase from fiscal 2016.
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for fiscal 2016 was $21.12M, a 10.70% increase from fiscal 2015.
- ROCKWELL MEDICAL, INC. selling, general and administrative expense for fiscal 2015 was $19.08M, a 4.14% increase from fiscal 2014.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $14.06M derived: sum of 2 quarters · filed 2019-03-18 | $19.75M derived: sum of 3 quarters · filed 2019-03-18 | $23.08M 10-K · filed 2019-03-18 | |
| 2018-09-30 | $6.16M 10-Q · filed 2018-11-09 | $11.85M derived: sum of 2 quarters · filed 2018-11-09 | $15.18M 10-Q · filed 2018-11-09 | $21.05M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-06-30 | $5.69M 10-Q · filed 2018-08-14 | $9.02M 10-Q · filed 2018-08-14 | $14.89M derived: sum of 3 quarters · filed 2018-08-14 | $19.68M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-03-31 | $3.33M 10-Q/A · filed 2018-08-14 | $5.06M 10-Q · filed 2018-05-10 | $9.20M derived: sum of 2 quarters · filed 2018-08-14 | $13.99M derived: sum of 3 quarters · filed 2018-11-09 | $20.53M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-12-31 | $5.87M 10-K · filed 2018-03-15 | $10.66M derived: sum of 2 quarters · filed 2018-11-09 | $17.20M derived: sum of 3 quarters · filed 2018-11-09 | $23.30M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $4.79M 10-Q · filed 2018-11-09 | $11.33M derived: sum of 2 quarters · filed 2018-11-09 | $17.43M 10-Q · filed 2018-11-09 | $23.48M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $6.54M 10-Q · filed 2018-08-14 | $12.64M 10-Q · filed 2018-08-14 | $18.69M derived: sum of 3 quarters · filed 2018-08-14 | $23.76M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $6.10M 10-Q/A · filed 2018-08-14 | $12.15M derived: sum of 2 quarters · filed 2018-08-14 | $17.22M derived: sum of 3 quarters · filed 2018-08-14 | $22.23M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2016-12-31 | $6.05M 10-K · filed 2018-03-15 | $11.12M derived: sum of 2 quarters · filed 2018-03-15 | $16.13M derived: sum of 3 quarters · filed 2018-03-15 | $21.12M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $5.07M 10-K · filed 2018-03-15 | $10.08M derived: sum of 2 quarters · filed 2018-03-15 | $15.07M 10-Q · filed 2017-11-08 | $21.16M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-06-30 | $5.01M 10-K · filed 2018-03-15 | $10.00M 10-Q · filed 2017-08-09 | $16.09M derived: sum of 3 quarters · filed 2018-03-15 | $19.92M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-03-31 | $4.99M 10-K · filed 2018-03-15 | $11.08M derived: sum of 2 quarters · filed 2018-03-15 | $14.90M derived: sum of 3 quarters · filed 2018-03-15 | $18.74M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2015-12-31 | $6.09M 10-K · filed 2017-03-15 | $9.92M derived: sum of 2 quarters · filed 2017-03-15 | $13.75M derived: sum of 3 quarters · filed 2017-03-15 | $19.08M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $3.83M 10-K · filed 2017-03-15 | $7.66M derived: sum of 2 quarters · filed 2017-03-15 | $12.99M 10-Q · filed 2016-11-07 | $18.91M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | $3.84M 10-K · filed 2017-03-15 | $9.16M 10-Q · filed 2016-08-09 | $15.08M derived: sum of 3 quarters · filed 2017-03-15 | $19.18M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-03-31 | $5.33M 10-K · filed 2017-03-15 | $11.24M derived: sum of 2 quarters · filed 2017-03-15 | $15.34M derived: sum of 3 quarters · filed 2017-03-15 | $19.56M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-12-31 | $5.92M 10-K · filed 2016-02-29 | $10.02M derived: sum of 2 quarters · filed 2016-02-29 | $14.23M derived: sum of 3 quarters · filed 2016-02-29 | $18.32M 10-K · filed 2017-03-15 | |
| 2014-09-30 | $4.10M 10-K · filed 2016-02-29 | $8.31M derived: sum of 2 quarters · filed 2016-02-29 | $12.40M 10-Q · filed 2015-11-09 | $16.20M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $4.21M 10-K · filed 2016-02-29 | $8.30M 10-Q · filed 2015-08-04 | $12.10M derived: sum of 3 quarters · filed 2016-02-29 | $15.49M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $4.09M 10-K · filed 2016-02-29 | $7.89M derived: sum of 2 quarters · filed 2016-02-29 | $11.27M derived: sum of 3 quarters · filed 2016-02-29 | $14.51M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $3.80M 10-K · filed 2015-03-03 | $7.18M derived: sum of 2 quarters · filed 2015-03-03 | $10.42M derived: sum of 3 quarters · filed 2015-03-03 | $14.34M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $3.39M 10-K · filed 2015-03-03 | $6.62M derived: sum of 2 quarters · filed 2015-03-03 | $10.54M 10-Q · filed 2014-11-10 | $14.18M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-06-30 | $3.24M 10-K · filed 2015-03-03 | $7.15M 10-Q · filed 2014-07-31 | $10.79M derived: sum of 3 quarters · filed 2015-03-03 | $14.12M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-03-31 | $3.92M 10-K · filed 2015-03-03 | $7.55M derived: sum of 2 quarters · filed 2015-03-03 | $10.88M derived: sum of 3 quarters · filed 2015-03-03 | $13.70M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2012-12-31 | $3.64M 10-K · filed 2014-03-07 | $6.96M derived: sum of 2 quarters · filed 2014-03-07 | $9.79M derived: sum of 3 quarters · filed 2014-03-07 | $12.68M 10-K · filed 2015-03-03 | |
| 2012-09-30 | $3.33M 10-K · filed 2014-03-07 | $6.15M derived: sum of 2 quarters · filed 2014-03-07 | $9.05M 10-Q · filed 2013-11-05 | $11.68M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-06-30 | $2.82M 10-K · filed 2014-03-07 | $5.72M 10-Q · filed 2013-08-01 | $8.35M derived: sum of 3 quarters · filed 2014-03-07 | $10.63M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-03-31 | $2.90M 10-K · filed 2014-03-07 | $5.53M derived: sum of 2 quarters · filed 2014-03-07 | $7.80M derived: sum of 3 quarters · filed 2014-03-07 | $10.17M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2011-12-31 | $2.63M 10-K · filed 2013-03-18 | $4.90M derived: sum of 2 quarters · filed 2013-03-18 | $7.28M derived: sum of 3 quarters · filed 2013-03-18 | $9.52M 10-K · filed 2014-03-07 | |
| 2011-09-30 | $2.27M 10-K · filed 2013-03-18 | $4.64M derived: sum of 2 quarters · filed 2013-03-18 | $6.89M 10-Q · filed 2012-11-09 | $9.35M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $2.37M 10-K · filed 2013-03-18 | $4.62M 10-Q · filed 2012-08-07 | $7.08M derived: sum of 3 quarters · filed 2013-03-18 | $9.51M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $2.25M 10-K · filed 2013-03-18 | $4.71M derived: sum of 2 quarters · filed 2013-03-18 | $7.14M derived: sum of 3 quarters · filed 2013-03-18 | $9.36M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2010-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $4.89M derived: sum of 2 quarters · filed 2013-03-18 | $7.11M derived: sum of 3 quarters · filed 2013-03-18 | $9.31M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $2.43M 10-Q · filed 2011-11-04 | $4.65M derived: sum of 2 quarters · filed 2011-11-04 | $6.85M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $2.22M 10-Q · filed 2011-08-05 | $4.42M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $6.91M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |